Yong Song Selected Research

Yong Song Research Topics

Disease

121	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 04/2008
95	Neoplasms (Cancer) 05/2024 - 07/2004
58	Lung Neoplasms (Lung Cancer) 11/2023 - 04/2008
32	Adenocarcinoma of Lung 11/2023 - 10/2009
27	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2009
22	Inflammation (Inflammations) 12/2023 - 09/2003
16	Acute Lung Injury 04/2024 - 04/2003
13	Pneumonia (Pneumonitis) 01/2024 - 01/2014
13	Lung Injury 04/2022 - 10/2009
12	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2024 - 09/2009
12	Disease Progression 02/2024 - 09/2013
11	Carcinogenesis 07/2022 - 09/2009
9	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2013
9	Malignant Pleural Effusion 09/2019 - 01/2012
8	Endometriosis 10/2023 - 04/2013
7	Pleural Effusion (Pleural Effusions) 04/2020 - 01/2012
7	Exanthema (Rash) 01/2020 - 01/2013
7	Asthma (Bronchial Asthma) 01/2019 - 03/2007
7	Hemorrhagic Shock 01/2009 - 04/2003
6	Brain Neoplasms (Brain Tumor) 04/2023 - 01/2017
6	Adenocarcinoma 12/2021 - 09/2009
5	Sepsis (Septicemia) 04/2022 - 08/2002
5	Carcinoma (Carcinomatosis) 12/2021 - 09/2009
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 01/2009
5	Lymphatic Metastasis 01/2017 - 01/2009
5	Lung Diseases (Lung Disease) 06/2015 - 04/2008
4	Infections 02/2024 - 03/2011
4	Wounds and Injuries (Trauma) 01/2024 - 01/2013
4	Necrosis 01/2022 - 12/2006
4	Food Hypersensitivity (Food Allergy) 02/2021 - 01/2017
4	Hemorrhage 02/2021 - 04/2003
4	Insulin Resistance 04/2016 - 11/2011
3	Bites and Stings (Sting) 04/2024 - 01/2021
3	COVID-19 02/2024 - 01/2021
3	Ventilator-Induced Lung Injury 10/2023 - 10/2018
3	Chronic Obstructive Pulmonary Disease (COPD) 06/2023 - 03/2007
3	Fibrosis (Cirrhosis) 01/2023 - 11/2019
3	Atrophy 01/2022 - 01/2014
3	Breast Neoplasms (Breast Cancer) 06/2021 - 04/2015

Drug/Important Bio-Agent (IBA)

34	Biomarkers (Surrogate Marker)IBA 02/2022 - 07/2004
33	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2009
28	ErbB Receptors (EGF Receptor)IBA 01/2024 - 03/2011
21	Immune Checkpoint InhibitorsIBA 01/2024 - 12/2017
16	Tyrosine Kinase InhibitorsIBA 09/2023 - 03/2011
14	Long Noncoding RNAIBA 03/2023 - 04/2015
11	PlatinumIBA 03/2024 - 03/2011
11	RNA (Ribonucleic Acid)IBA 10/2022 - 04/2004
10	MicroRNAs (MicroRNA)IBA 10/2023 - 09/2012
9	CytokinesIBA 01/2023 - 07/2012
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 09/2009
9	Small Interfering RNA (siRNA)IBA 01/2020 - 11/2013
9	Messenger RNA (mRNA)IBA 01/2019 - 09/2005
8	LipopolysaccharidesIBA 04/2024 - 09/2005
8	icotinibIBA 02/2020 - 09/2013
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017 - 04/2003
7	CrizotinibIBA 02/2024 - 01/2015
6	Anaplastic Lymphoma KinaseIBA 02/2024 - 01/2015
6	LigandsIBA 01/2024 - 04/2015
5	InterferonsIBA 04/2024 - 04/2020
5	osimertinibIBA 09/2023 - 01/2019
5	Docetaxel (Taxotere)FDA Link 12/2022 - 07/2014
5	Interleukin-6 (Interleukin 6)IBA 11/2022 - 07/2012
5	Gefitinib (Iressa)FDA Link 12/2020 - 03/2011
5	Cadherins (E-Cadherin)IBA 10/2019 - 11/2013
5	CateninsIBA 02/2017 - 04/2015
4	Indicators and Reagents (Reagents)IBA 11/2022 - 06/2012
4	Phosphotransferases (Kinase)IBA 11/2022 - 05/2014
4	Topotecan (Hycamtin)FDA LinkGeneric 04/2022 - 10/2018
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2018
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 11/2012
4	VimentinIBA 12/2021 - 11/2013
4	Carcinoembryonic AntigenIBA 08/2021 - 04/2014
4	AlbuminsIBA 03/2021 - 09/2014
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 03/2011
4	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2014
4	Farnesyltranstransferase (Farnesyltransferase)IBA 01/2021 - 01/2018
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2008
4	Circulating Tumor DNAIBA 01/2021 - 04/2020
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 09/2005
4	Mitochondrial DNA (mtDNA)IBA 11/2019 - 01/2013
4	HMGB1 Protein (HMG1)IBA 10/2017 - 09/2009
4	enhanced green fluorescent proteinIBA 09/2012 - 07/2010
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 03/2012 - 08/2002
3	Etoposide (VP 16)FDA LinkGeneric 03/2024 - 01/2018
3	ensartinibIBA 02/2024 - 01/2020
3	Programmed Cell Death 1 ReceptorIBA 01/2023 - 01/2022
3	Estrogens (Estrogen)FDA Link 01/2023 - 04/2013
3	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 04/2022 - 01/2019
3	Gemcitabine FDA Link 01/2022 - 09/2014
3	Tumor Biomarkers (Tumor Markers)IBA 12/2021 - 02/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 09/2011

Therapy/Procedure

43	Therapeutics 01/2024 - 12/2008
42	Drug Therapy (Chemotherapy) 06/2023 - 09/2009
24	Immunotherapy 05/2024 - 03/2014
7	Radiotherapy 06/2023 - 09/2009
6	Artificial Respiration (Mechanical Ventilation) 10/2023 - 05/2014
6	Punctures 04/2022 - 09/2005
3	Neoadjuvant Therapy 11/2023 - 01/2022
3	Lymph Node Excision (Lymph Node Dissection) 11/2023 - 02/2015
3	Lasers (Laser) 01/2022 - 04/2008